Decrease of phosphorylated proto-oncogeneCREBat Ser 133 site inhibits growth and metastatic activity of renal cell cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decrease of phosphorylated proto-oncogeneCREBat Ser 133 site inhibits growth and metastatic activity of renal cell cancer

Published:2015-06-03 Issue:7 Volume:19 Page:985-995
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Wang Xue,Ren Yu,Zhuang Haihui,Meng Xiangyu,Huang Shuaishuai,Li Yanyuan,Hehir Michael,Wang Ping

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.2015.1053208

Reference50 articles.

1. Renal cell carcinoma

2. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation

3. Treatment of metastatic renal cell carcinoma

4. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133

5. CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy: Fig. 1.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal cancer: signaling pathways and advances in targeted therapies;MedComm;2024-08

2. Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review;Medicine;2024-05-24

3. Sinularin stabilizes FOXO3 protein to trigger prostate cancer cell intrinsic apoptosis;Biochemical Pharmacology;2024-02

4. Molecular insight into renal cancer and latest therapeutic approaches to tackle it: an updated review;Medical Oncology;2023-11-13

5. ZNRF2 as an oncogene is transcriptionally regulated by CREB1 in breast cancer models;Human Cell;2023-05-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3